ARGX:EBR
argenx SE
€912.40
arrow_upward
+1.31%(+11.80) 1D
Sep 3, 5:35:34 PM GMT+2 · EUR
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ARGX...
Open
€912.00
High
€924.60
Low
€904.00
Mkt. cap
57.83B
Avg. vol.
86.11K
Volume
98.42K
P/E ratio
40.18
52-wk high
€925.00
52-wk low
€568.40
EPS
€22.71
Shares outstanding
35.93M
No. of employees
2K
Open
€912.00
High
€924.60
Low
€904.00
Mkt. cap
57.83B
Avg. vol.
86.11K
Volume
98.42K
P/E ratio
40.18
52-wk high
€925.00
52-wk low
€568.40
EPS
€22.71
Shares outstanding
35.93M
No. of employees
2K
News stories
From web sources and news partners
AD HOC NEWS
·
8 hours ago
Argenx stock gains as Jefferies lifts price target and Q2 2026 beat stays in focus
AD HOC NEWS
·
1 day ago
Argenx stock hits new 52-week high as Q2 2026 growth stays in focus
Currently.com
·
1 day ago
Argenx Has Delivered 18 Consecutive Quarters of Sales Growth -- but Is the Biotech Stock Still Underrated?
TipRanks
·
2 days ago
Argenx to Highlight Autoimmune Pipeline at Key U.S. Healthcare Conferences
Profile
Argenx SE is a Belgian-Dutch pharmaceutical company specializing in immunology. Argenx specializes in the development of antibody therapies for the treatment of autoimmune diseases and cancer. Its work primarily focuses on the development of orphan drugs. Wikipedia
About argenx SE